⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBRX News
ImmunityBio, Inc. Common Stock
Form 8-K
sec.gov
IBRX
ImmunityBio Addresses FDA Correspondence and Reaffirms Commitment to Advertising Compliance
businesswire.com
IBRX
IBRX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
IBRX
IBRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ImmunityBio, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
IBRX
Pomerantz LLP Advises Shareholders of Class Action Filing Against ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
ImmunityBio, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IBRX
prnewswire.com
IBRX
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
IBRX
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
accessnewswire.com
IBRX
Pomerantz LLP Advises Shareholders of Class Action Involving ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
IBRX